Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
03/2005
03/24/2005US20050065179 Novel derivatives of benzimidazole and imidazo-pyridine and their use as medicaments
03/24/2005US20050065170 Compounds
03/24/2005US20050065066 Stabilised insulin compositions
03/24/2005CA2541100A1 Quinazoline derivatives
03/24/2005CA2539049A1 Quinazoline derivatives
03/24/2005CA2539024A1 Quinazoline derivatives as antitumor agents
03/24/2005CA2538909A1 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors
03/24/2005CA2538420A1 Quinolone antibacterial agents
03/24/2005CA2538413A1 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
03/24/2005CA2538315A1 Matrix metalloproteinase inhibitors
03/24/2005CA2536633A1 Fused ring heterocycles as potassium channel modulators
03/24/2005CA2482232A1 Protease inhibitor conjugates and antibodies useful in immunoassay
03/23/2005EP1516876A1 Mediators of hedgehog signalling pathways, compositions and uses related thereto
03/23/2005EP1516871A1 Benzoindoline derivatives with adrenergic activity
03/23/2005EP1515955A2 Chemical process
03/23/2005EP1515953A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
03/23/2005EP1515724A1 Mitotic kinesin inhibitors
03/23/2005EP1515723A2 Substituted dihydropyrimidones and dihydropyrimidinethiones as calcium channel blockers
03/23/2005EP1515721A1 Ophthalmic compositions for treating ocular hypertension
03/23/2005EP1515680A2 Use of thio-oxindole derivatives in treatment of skin disorders
03/23/2005EP1280795B1 N-substituted carbamoyloxyalkyl-azolium derivatives
03/23/2005EP1028949B1 Carbamoylphenylsulfonyl ureas, method for their production and their application as herbicides and plant growth regulators
03/23/2005CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists
03/23/2005CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/23/2005CN1599727A Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them
03/23/2005CN1599726A Pyrimidine compounds
03/23/2005CN1599724A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
03/23/2005CN1599718A Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
03/23/2005CN1599717A Cyclic diamine compounds having fused-ring groups
03/23/2005CN1597667A Quinazoline derivatives as angiogenesis inhibitors
03/23/2005CN1193788C Beta 2-adrenergic receptor agonist
03/22/2005US6870055 Heterocyclic amides such as 3-dimethylaminomethyl-6-methoxy-2 -methyl-4-phenyl-2H-isoquinoline-1-one, used as antiarrhythmic agents
03/22/2005US6869957 Non-peptide tachykinin receptor antagonists
03/22/2005US6869943 Sorbitol dehydrogenase inhibitors
03/22/2005US6869913 Pyridazin-3-one derivatives, their use and intermediates for their production
03/17/2005WO2005023799A1 Fused bicyclic carboxamide derivatives and methods of their use
03/17/2005WO2005023765A1 Method for catalyzing amidation reactions by the presence of co2
03/17/2005WO2005023761A2 Cytokine inhibitors
03/17/2005WO2005023760A2 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics
03/17/2005WO2005023251A1 N3 alkylated benzimidazole derivatives as mek inhibitors
03/17/2005WO2005023248A1 TGF-β GENE EXPRESSION INHIBITOR
03/17/2005WO2005023246A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp)
03/17/2005WO2005005415A8 Indoles useful in the treatment of inflammation
03/17/2005WO2002079193A8 Inhibitors of cyclin dependent kinases as anti-cancer agent
03/17/2005US20050059828 Process for the preparation of eletriptan
03/17/2005US20050059824 Using carbon dioxide; salt formation, hydrolysis
03/17/2005US20050059726 For treating thrombosis and factor xa-related cardiovascular and neurodegenerative diseases; 6-Chloro-N-{(3S)-1-[3-fluoro-2'-(methylsulfonyl)-1,1'-biphenyl-4-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide for example
03/17/2005US20050059722 Kinase inhibitors, such as focal adhesion kinase (FAK) inhibitors; treating cancer; 2-methylsulfonyl-N-(3-thiophen-2-yl-1H-indazol-5-yl)benzenesulfonamide for example
03/17/2005US20050059702 Elevate the progenitor and/or stem cell population in peripheral blood or bone marrow; treatment of HIV, inflammatory condition like rheumatoid arthritis, tumor, asthma; 4-(3,3''-Dimethyl-3',4',5',6'-tetrahydro-2'H-cis-[2,2';6',2'']terpyridin-1'-yl-butylamine
03/17/2005US20050059699 N-acylated lipophilic amino acid derivatives
03/17/2005US20050059687 Modulators of ATP-Binding Cassette transporters
03/17/2005US20050059676 Cyclic pyrazinoylguanidine sodium channel blockers
03/17/2005US20050059675 Antidepressants; N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-1,2-dihydro-3H-benzo[e]indole-3-carboxamide; antagonist of adrenergic receptor, serotonin receptor; anxiety, schizophrenia, Parkinson's disease, cognitive disorders, schizophrenia
03/17/2005US20050059671 Hydroxyiminopiperazine compound for therapy and prophylaxis of Urinary incontinence, Inflammatory-bowel disease, addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder
03/17/2005US20050059666 CCR5 antagonists useful for treating AIDS
03/17/2005US20050059663 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient
03/17/2005US20050059662 Substituted quinazolinone compounds
03/17/2005US20050058917 Charge transport compound containing at least two carbazolecarboxaldehyde substituted- hydrazone groups
03/17/2005US20050058635 Anticancer agents; therapy for infections; administering glutaminyl cyclase inhibitor; Alzheimer's disease; Down syndrome; controlling fertility; schizophrenia; skin disorders
03/17/2005DE10337942A1 Aminobenzimidazolderivate Aminobenzimidazolderivate
03/17/2005CA2538820A1 Cytokine inhibitors
03/17/2005CA2537677A1 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics
03/17/2005CA2537098A1 N3 alkylated benzimidazole derivatives as mek inhibitors
03/17/2005CA2537097A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp)
03/17/2005CA2536967A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
03/16/2005EP1513832A2 Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
03/16/2005EP1513830A1 Bisindolyl-maleimid derivatives as kinase inhibitors
03/16/2005EP1513821A1 Protein kinase inhibitors
03/16/2005EP1513817A1 1, 2-azole derivatives with hypoglycemic and hypolipidemic activity
03/16/2005EP1513812A1 Substituted indoles
03/16/2005EP1513809A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
03/16/2005EP1513807A1 Pharmaceutical combination
03/16/2005EP1513589A1 1,5-disubstituted pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma
03/16/2005EP1513523A1 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
03/16/2005EP1513520A2 Substituted pyrrolines as kinase inhibitors
03/16/2005EP1399436B1 Oxytocin agonists
03/16/2005EP1355903B1 Pyrazole derivatives against tgf overexpression
03/16/2005EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/16/2005EP1189640B1 Complex of eletriptan and sulphobutylether-cyclodextrin and its use for the treatment of migraine
03/16/2005EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
03/16/2005CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
03/16/2005CN1596247A Lactam derivatives as antagonists for human 11CBY receptors
03/16/2005CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer
03/16/2005CN1193027C Substituted pyrroles
03/16/2005CN1193026C Z-pyrazoline-5-ones
03/16/2005CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same
03/16/2005CA2480218A1 New derivatives of benzoindoline, preparation thereof, and pharmaceutical compounds containing them
03/15/2005US6867222 Nociceptin analogs
03/15/2005US6867221 Cyclic amine compounds and pharmaceutical composition containing the same
03/15/2005US6867210 For treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis, acute or chronic pain, as antitinnitus agents, anticonvulsants, antimanic depressants, local anesthetics, antiarrhythmics
03/15/2005US6867209 Indole-type derivatives as inhibitors of p38 kinase
03/15/2005US6867207 IL-5 inhibiting 6-azauracil derivatives
03/15/2005US6867205 Useful for the treatment and/or prophylaxis of diseases associated with dipeptidyl peptidase, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance
03/15/2005US6867201 For therapy of abnormal cell growth, such as cancer, in mammals
03/15/2005US6867200 Anticancer agents; anticoagulants
03/15/2005US6867184 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors
03/15/2005CA2146852C New substituted pyrazole derivatives, processes for their preparation and their use as herbicides
03/15/2005CA2063671C Aminoguanidines
03/10/2005WO2005021537A1 N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
03/10/2005WO2005021536A2 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors